Health Canada

Neuralink, the brain implant company founded by Elon Musk, has received approval from Health Canada to launch its first clinical trial in the country. What Happened: On Wednesday, University Health Network announced that the trial would occur at Toronto Western Hospital. UHN CEO Kevin Smith said...

Health Canada has instructed five licensed cannabis companies to halt the sale of specific ingestible marijuana products categorized as "ingestible extracts" instead of edibles. In Canada, edibles face a maximum THC limit of 10 milligrams per package, while extracts or...

Health Canada has approved BeiGene Ltd (NASDAQ: BGNE) Brukinsa (zanubrutinib) for the treatment of mantle cell lymphoma (MCL) in adult patients who have received at least one prior therapy. This is the second approval for Brukinsa in Canada, following its initial approval in March for...

Canada’s health regulator was launching a probe into Pfizer Inc’s (NYSE: PFE) arthritis drug, Xeljanz and Xeljanz XR (tofacitinib), after a trial by the company identified an increased risk of serious heart-related issues and cancer in the participants. The...

Health Canada has approved ElectroCore Inc's (NASDAQ: ECOR) gammaCore Sapphire family of products to prevent and treat migraine and cluster headache. GammaCore Sapphire will be distributed in Canada by RSK Medical Inc, under an exclusive distribution agreement...

Imv Inc (NASDAQ: IMV) share are ripping higher on above-average volume following an update by the company on its coronavirus vaccine program. What Happened? The Dartmouth, Nova Scotia-based company said it's rapidly progressing in developing DPX-COVID-19, its vaccine candidate against SARS-...

Shares of cannabis company CannTrust Holdings Inc (NYSE: CTST) fell 25% early Monday after the company said it accepts a new negative Health Canada ruling. What Happened CannTrust said in a press release that it failed a Health Canada inspection during the period of July 10-16. The company...

Less than a month after cannabis producer CannTrust Holdings Inc (NYSE: CTST) was issued a noncompliance report from Canadian regulators for growing marijuana on unlicensed property, CannTrust investors received some more bad news on Friday when the company said its auditor has withdrawn all its...

Shares of medical and recreational cannabis producer CannTrust Holdings Inc (NYSE: CTST) gained more than 8% Wednesday morning after confirming an exploration into strategic alternatives. What Happened CannTrust established a special committee after Health Canada found the company to be producing...

Shares of CannTrust Holdings Inc (NYSE: CTST) traded higher Friday morning after the cannabis producer confirmed senior leadership changes. What Happened CannTrust agreed with Health Canada's findings it produced cannabis in multiple unlicensed rooms in early July. A special committee was...

Medical and recreational cannabis producer CannTrust Holdings Inc (NYSE: CTST) said Monday that it's forming a special committee to "restore trust" after its facility was found to be non-compliant with Canadian government regulations. What Happened Health Canada is actively...

Cannabis producer company CannTrust Holdings Inc (NYSE: CTST) said Monday that it accepts a Health Canada non-compliance finding; this "sharp turn of events" prompted Bank of America Merrill Lynch to double downgrade the stock. The Analyst Christopher Carey downgraded CannTrust...

"420 Investor" Alan Brochstein has a simple message to CannTrust Holdings Inc (NYSE: CTC) CEO Peter Aceto: apologize for violating Health Canada rules and resign. What Happened CannTrust said in a press release Monday that it "accepted" a Health Canada finding that some of its...